{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:15:17Z","timestamp":1793304917888,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Major Science and Technology Project of Changzhou Municipal Health Commission","award":["No.ZD202331"],"award-info":[{"award-number":["No.ZD202331"]}]},{"name":"Top Talent of Changzhou \u201cThe 14th Five-Year Plan\u201d High-Level Health Talents Training Project","award":["2024CZBJ002"],"award-info":[{"award-number":["2024CZBJ002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09167-9","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:56:40Z","timestamp":1753279000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RUNX2 mediated epithelial mesenchymal transition induced by TGF beta and Smad signaling promotes malignant progression in glioma"],"prefix":"10.1038","volume":"15","author":[{"given":"Peng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"9167_CR1","first-page":"435","volume":"5","author":"Chinese Glioma Cooperative Group","year":"2014","unstructured":"Chinese Glioma Cooperative Group. G. A. P. Guidelines for molecular diagnosis and treatment of glioma in China. Chin. J. Neurosurg. 5, 435\u2013444 (2014).","journal-title":"Chin. J. Neurosurg."},{"key":"9167_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer. 13, 97\u2013110. https:\/\/doi.org\/10.1038\/nrc3447 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"9167_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. EMT transition States during tumor progression and metastasis. Trends Cell Biol. 29, 212\u2013226. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001 (2019).","journal-title":"Trends Cell Biol."},{"key":"9167_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3892\/or.2019.7428","volume":"43","author":"B Liu","year":"2020","unstructured":"Liu, B., Liu, J., Yu, H., Wang, C. & Kong, C. Transcription factor RUNX2 regulates epithelial\u2013mesenchymal transition and progression in renal cell carcinomas. Oncol. Rep. 43, 609\u2013616. https:\/\/doi.org\/10.3892\/or.2019.7428 (2020).","journal-title":"Oncol. Rep."},{"key":"9167_CR5","doi-asserted-by":"publisher","unstructured":"Park, M. et al. Breast cancer metastasis: mechanisms and therapeutic implications. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23126806 (2022).","DOI":"10.3390\/ijms23126806"},{"key":"9167_CR6","doi-asserted-by":"publisher","first-page":"114395","DOI":"10.1016\/j.biopha.2023.114395","volume":"160","author":"E Sabouni","year":"2023","unstructured":"Sabouni, E. et al. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: metastasis, therapy response, and revisiting molecular pathways. Biomed. Pharmacother. Biomed. Pharmacother. 160, 114395. https:\/\/doi.org\/10.1016\/j.biopha.2023.114395 (2023).","journal-title":"Biomed. pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"9167_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12967-020-02644-x","volume":"19","author":"M Parol","year":"2021","unstructured":"Parol, M., Gzil, A., Bodnar, M. & Grzanka, D. Systematic review and meta-analysis of the prognostic significance of MicroRNAs related to metastatic and EMT process among prostate cancer patients. J. Trans. Med. 19, 28. https:\/\/doi.org\/10.1186\/s12967-020-02644-x (2021).","journal-title":"J. Translational Med."},{"key":"9167_CR8","doi-asserted-by":"publisher","unstructured":"Mevel, R., Draper, J. E., Lie, A. L. M., Kouskoff, V. & Lacaud, G. RUNX transcription factors: orchestrators of development. Dev. (Cambridge England). 146 https:\/\/doi.org\/10.1242\/dev.148296 (2019).","DOI":"10.1242\/dev.148296"},{"key":"9167_CR9","doi-asserted-by":"publisher","first-page":"188715","DOI":"10.1016\/j.bbcan.2022.188715","volume":"1877","author":"TC Lin","year":"2022","unstructured":"Lin, T. C. RUNX1 and cancer. Biochim. Et Biophys. Acta Reviews cancer. 1877, 188715. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188715 (2022).","journal-title":"Biochim. Et Biophys. Acta Reviews cancer"},{"key":"9167_CR10","doi-asserted-by":"publisher","unstructured":"Lin, T. C. RUNX2 and cancer. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24087001 (2023).","DOI":"10.3390\/ijms24087001"},{"key":"9167_CR11","doi-asserted-by":"publisher","unstructured":"Chuang, L. S. H., Matsuo, J., Douchi, D., Bte Mawan, N. A. & Ito, Y. RUNX3 in stem cell and cancer biology. Cells 12, (2023). https:\/\/doi.org\/10.3390\/cells12030408","DOI":"10.3390\/cells12030408"},{"key":"9167_CR12","doi-asserted-by":"publisher","unstructured":"Komori, T. Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20071694 (2019).","DOI":"10.3390\/ijms20071694"},{"key":"9167_CR13","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41418-022-01010-2","volume":"29","author":"X Yin","year":"2022","unstructured":"Yin, X. et al. RUNX2 recruits the NuRD(MTA1)\/CRL4B complex to promote breast cancer progression and bone metastasis. Cell Death Differ. 29, 2203\u20132217. https:\/\/doi.org\/10.1038\/s41418-022-01010-2 (2022).","journal-title":"Cell Death Differ."},{"key":"9167_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1476-4598-9-258","volume":"9","author":"SK Baniwal","year":"2010","unstructured":"Baniwal, S. K. et al. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol. Cancer. 9, 258. https:\/\/doi.org\/10.1186\/1476-4598-9-258 (2010).","journal-title":"Mol. Cancer"},{"key":"9167_CR15","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s11064-018-2626-4","volume":"43","author":"D Yamada","year":"2018","unstructured":"Yamada, D. et al. RUNX2 promotes malignant progression in glioma. Neurochem. Res. 43, 2047\u20132054. https:\/\/doi.org\/10.1007\/s11064-018-2626-4 (2018).","journal-title":"Neurochem. Res."},{"key":"9167_CR16","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1038\/s41388-020-1351-z","volume":"39","author":"H Yi","year":"2020","unstructured":"Yi, H. et al. Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT. Oncogene 39, 5152\u20135164. https:\/\/doi.org\/10.1038\/s41388-020-1351-z (2020).","journal-title":"Oncogene"},{"key":"9167_CR17","doi-asserted-by":"publisher","unstructured":"Yan, X. et al. RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells. Cancer Cell Int. 20 https:\/\/doi.org\/10.1186\/s12935-020-01544-w (2020).","DOI":"10.1186\/s12935-020-01544-w"},{"key":"9167_CR18","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.7150\/jca.50631","volume":"12","author":"L Wei","year":"2021","unstructured":"Wei, L., Shao, N., Peng, Y. & Zhou, P. Inhibition of cathepsin S restores TGF-beta-induced Epithelial-to-mesenchymal transition and tight junction turnover in glioblastoma cells. J. Cancer. 12, 1592\u20131603. https:\/\/doi.org\/10.7150\/jca.50631 (2021).","journal-title":"J. Cancer"},{"key":"9167_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/hcs2.87","volume":"3","author":"O Espinosa","year":"2024","unstructured":"Espinosa, O., Puentes, G., Rodriguez, J., Robayo, A. & Anaya, J. M. Science, technology, and innovation in health for the next twenty years: A survey analysis in Colombia. Health Care Sci. 3, 78\u201387. https:\/\/doi.org\/10.1002\/hcs2.87 (2024).","journal-title":"Health Care Sci."},{"key":"9167_CR20","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/annonc\/mdz164","volume":"30","author":"BW Kristensen","year":"2019","unstructured":"Kristensen, B. W., Priesterbach-Ackley, L. P., Petersen, J. K. & Wesseling, P. Molecular pathology of tumors of the central nervous system. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 30, 1265\u20131278. https:\/\/doi.org\/10.1093\/annonc\/mdz164 (2019).","journal-title":"Annals Oncology: Official J. Eur. Soc. Med. Oncol."},{"key":"9167_CR21","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s13311-022-01238-3","volume":"19","author":"JJ Miller","year":"2022","unstructured":"Miller, J. J., Targeting, I. D. H. M. & Glioma Neurotherapeutics: J. Am. Soc. Experimental Neurother. 19, 1724\u20131732, doi:https:\/\/doi.org\/10.1007\/s13311-022-01238-3 (2022).","journal-title":"Neurotherapeutics: J. Am. Soc. Experimental Neurother."},{"key":"9167_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ajpath.2023.01.004","volume":"193","author":"A Roy","year":"2023","unstructured":"Roy, A. et al. Protein kinase D2 and D3 promote prostate Cancer cell bone metastasis by positively regulating Runx2 in a MEK\/ERK1\/2-Dependent manner. Am. J. Pathol. 193, 624\u2013637. https:\/\/doi.org\/10.1016\/j.ajpath.2023.01.004 (2023).","journal-title":"Am. J. Pathol."},{"key":"9167_CR23","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1038\/s41418-021-00810-2","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. CBF\u03b2 promotes colorectal cancer progression through transcriptionally activating OPN, FAM129A, and UPP1 in a RUNX2-dependent manner. Cell Death Differ. 28, 3176\u20133192. https:\/\/doi.org\/10.1038\/s41418-021-00810-2 (2021).","journal-title":"Cell Death Differ."},{"key":"9167_CR24","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/jnr.21686","volume":"86","author":"V Vladimirova","year":"2008","unstructured":"Vladimirova, V., Waha, A., L\u00fcckerath, K., Pesheva, P. & Probstmeier, R. Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J. Neurosci. Res. 86, 2450\u20132461. https:\/\/doi.org\/10.1002\/jnr.21686 (2008).","journal-title":"J. Neurosci. Res."},{"key":"9167_CR25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2478\/jtim-2022-0013","volume":"10","author":"S Pan","year":"2022","unstructured":"Pan, S., Sun, S., Liu, B. & Hou, Y. Pan-cancer landscape of the RUNX protein family reveals their potential as carcinogenic biomarkers and the mechanisms underlying their action. J. Translational Intern. Med. 10, 156\u2013174. https:\/\/doi.org\/10.2478\/jtim-2022-0013 (2022).","journal-title":"J. Translational Intern. Med."},{"key":"9167_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"9167_CR27","doi-asserted-by":"publisher","unstructured":"Manfioletti, G., Fedele, M. & Epithelial-Mesenchymal Transition (eds) Intl. J. Mol. Sci. 23, EMT) (2021). https:\/\/doi.org\/10.3390\/ijms23105848 (2022).","DOI":"10.3390\/ijms23105848"},{"key":"9167_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal, V. Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol. 13, 395\u2013412. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043854 (2018).","journal-title":"Annu. Rev. Pathol."},{"key":"9167_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ctrv.2011.11.001","volume":"38","author":"C Foroni","year":"2012","unstructured":"Foroni, C., Broggini, M., Generali, D. & Damia, G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat. Rev. 38, 689\u2013697. https:\/\/doi.org\/10.1016\/j.ctrv.2011.11.001 (2012).","journal-title":"Cancer Treat. Rev."},{"key":"9167_CR30","doi-asserted-by":"publisher","unstructured":"Lo, U. G., Lee, C. F., Lee, M. S. & Hsieh, J. T. The role and mechanism of epithelial-to-mesenchymal transition in prostate cancer progression. Int. J. Mol. Sci. 18 https:\/\/doi.org\/10.3390\/ijms18102079 (2017).","DOI":"10.3390\/ijms18102079"},{"key":"9167_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","volume":"19","author":"J Xu","year":"2009","unstructured":"Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156\u2013172. https:\/\/doi.org\/10.1038\/cr.2009.5 (2009).","journal-title":"Cell Res."},{"key":"9167_CR32","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","volume":"7","author":"DM Gonzalez","year":"2014","unstructured":"Gonzalez, D. M. & Medici, D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 7, re8. https:\/\/doi.org\/10.1126\/scisignal.2005189 (2014).","journal-title":"Sci. Signal."},{"key":"9167_CR33","doi-asserted-by":"publisher","unstructured":"Coelho, B. P. et al. Multifaceted WNT signaling at the crossroads between epithelial-mesenchymal transition and autophagy in glioblastoma. Front. Oncol. 10 https:\/\/doi.org\/10.3389\/fonc.2020.597743 (2020).","DOI":"10.3389\/fonc.2020.597743"},{"key":"9167_CR34","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/labinvest.2012.84","volume":"92","author":"DF Niu","year":"2012","unstructured":"Niu, D. F. et al. Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas. Lab. Invest. 92, 1181\u20131190. https:\/\/doi.org\/10.1038\/labinvest.2012.84 (2012).","journal-title":"Lab. Invest."},{"key":"9167_CR35","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1158\/0008-5472.Can-14-0053","volume":"74","author":"TW Owens","year":"2014","unstructured":"Owens, T. W. et al. Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. Cancer Res. 74, 5277\u20135286. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-0053 (2014).","journal-title":"Cancer Res."},{"key":"9167_CR36","doi-asserted-by":"publisher","first-page":"e2572","DOI":"10.1038\/cddis.2017.15","volume":"8","author":"M Colden","year":"2017","unstructured":"Colden, M. et al. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Cell Death Dis. 8, e2572. https:\/\/doi.org\/10.1038\/cddis.2017.15 (2017).","journal-title":"Cell Death Dis."},{"key":"9167_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1242\/dmm.015040","volume":"7","author":"L McDonald","year":"2014","unstructured":"McDonald, L. et al. RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland. Dis. Model. Mech. 7, 525\u2013534. https:\/\/doi.org\/10.1242\/dmm.015040 (2014).","journal-title":"Dis. Model. Mech."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09167-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09167-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:56:41Z","timestamp":1753279001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09167-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9167"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09167-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All human tissue-related procedures were approved by the Institutional Ethics Committee of [The Third Affliated Hospital of Soochow University] (Approval No. 2023(\u6559)CL041) and conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}}],"article-number":"26781"}}